Bushu Pharmaceuticals wins 2024 APAC award for excellence in quality, delivery, and sustainability.
Bushu Pharmaceuticals has been awarded the 2024 APAC Customer Value Leadership Award by Frost & Sullivan for excelling in quality assurance, timely delivery, sustainability, and cost efficiency in the pharmaceutical manufacturing industry. The company, with operations in 56 countries, specializes in services ranging from product development to supply chain management, aiding over 95 clients, half of whom are from abroad. Bushu Pharma's innovative services and strategic partnerships streamline market entry and enhance healthcare accessibility.
Articles
Further Reading
You have 12 free stories remaining this month. Subscribe anytime for unlimited access.